Method for constructing sequencing library of target sequence
A technology for sequencing libraries and target sequences, applied in the field of building sequencing libraries of target sequences, can solve problems such as high detection cost, lower target sequence ratio, lower capture efficiency, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0312] Example 1: The library construction (C) of the linker of the present invention without a blocking agent, and the IDT commercial long linker control plus sealing Library construction with blocking agent (K), IDT commercial adapter control plus blocking agent library construction (M), IDT commercial long adapter pair According to the library construction without blocking agent (J1), and IDT commercial linker control library construction without blocking agent (J2) Compare
[0313] Sample: commercialized tumor mutation standard diluted to a certain mutation ratio (Jingliang Gene, tumor SNV 5% gDNA standard, Cat. No. GWOGTM1003).
[0314] Targets: 400K, including 86 tumor-related genes (IDT synthesized 120nt 5-end biotin-modified probe pool).
[0315] Linker: (1) linker of the present invention (31 nucleotides) (Example C, see sequence listing for sequence); (2) commercialized long linker control (xGen Dual index with UMI Adapter) purchased from IDT (for comparison ...
Embodiment 2
[0321] Example 2: The linker of various lengths of the present invention does not add the library construction of blocking agent, the library construction of long adapter control without adding blocking agent, and the library construction (CK) of IDT commercial long adapter control plus blocking agent Comparison.
[0322] Sample: same as Example 1.
[0323] Target: same as Example 1.
[0324]Linkers: (1) linkers of various lengths of the present invention (16 nucleotides, 20 nucleotides, 24 nucleotides, 31 nucleotides, 34 nucleotides, 37 nucleotides, 40 nucleotides); (2) the long linker control (62 nucleotides) designed by the inventors themselves according to the Illumina platform; and (3) the commercialized long linker control (same as Example 1) purchased from IDT (CK). See the sequence listing for linker sequences.
[0325] The first round of amplification: For adapters of various lengths in the present invention, an intermediate library (or pre-library) is prepared. ...
Embodiment 3
[0330] Example 3: Verified in clinical application, the comparison between the library construction of the adapter of the present invention without blocking and the library construction of IDT commercial adapter plus blocking agent.
[0331] Samples: fresh clinical tumor tissue samples from co-constructed laboratories (12 cases)
[0332] Target: 39M whole exome, derived from IDT xGen Exome Research Panel v1.0, Cat. No. 1056115.
[0333] Linker: (1) the linker of the present invention (31 nucleotides); and (2) a commercially available long linker control purchased from IDT (same as Example 1). See the sequence listing for linker sequences.
[0334] The first round of amplification: for the adapter of the present invention, an intermediate library (or pre-library) is prepared. For the commercially available long linker controls purchased from IDT, what has been constructed is already a complete genome-wide library. See the sequence listing for the corresponding primer sequenc...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


